SCHEMBL21176647

SCHEMBL21176647

CC/C=C(\C)CCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
SLC15A2 Q16348 1/20 0.48
EGLN1 Q9GZT9 2/20 0.45
ALKBH5 Q6P6C2 1/20 0.45
SUCNR1 Q9BXA5 1/20 0.45
FFAR3 O14843 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
IMPDH2 P12268 11/20 0.42
FNTA P49354 2/20 0.41
FNTB P49356 2/20 0.41
KDM4E B2RXH2 1/20 0.41
KDM6B O15054 1/20 0.41
KDM5C P41229 1/20 0.41
PHF8 Q9UPP1 1/20 0.41
KDM2A Q9Y2K7 1/20 0.41
FFAR1 O14842 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8468128 1.00 LMNA (0.48) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL17706760 0.80 LMNA (0.48) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL17670755 0.80 MEN1 (0.50) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL8927123 0.80 FNTA (0.55) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL17670753 0.80 MEN1 (0.50) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL11751993 0.80 LMNA (0.48) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL17706805 0.80 LMNA (0.48) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL23883139 0.79 LMNA (0.42) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL22555420 0.79 LMNA (0.42) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL23883141 0.79 LMNA (0.42) LMNASLC15A2EGLN1ALKBH5SUCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260013535-A1 STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS CARGILL, INCORPORATED (US) 2026-01-15 US disclosed
US-12458049-B2 Steviol glycoside solubility enhancers CARGILL, INCORPORATED (US) 2025-11-04 US disclosed
CN-110869348-B Pyrrole compound, perfume composition, and cosmetic containing the same 长谷川香料株式会社 2023-09-12 CN disclosed
US-11717549-B2 Steviol glycoside solubility enhancers CARGILL, INCORPORATED (US) 2023-08-08 US disclosed
CN-116098279-A Matcha flavor imparting composition 长谷川香料株式会社 2023-05-12 CN disclosed
CN-116103086-A Tea flavor imparting composition 长谷川香料株式会社 2023-05-12 CN disclosed
US-20220323528-A1 STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS CARGILL, INCORPORATED (US) 2022-10-13 US disclosed
US-11332694-B2 Pyrrole compound, method of making same, and aroma composition, food, drink and cosmetics containing same T. HASEGAWA CO., LTD. (JP) 2022-05-17 US disclosed
US-20200157463-A1 PYRROLE COMPOUND, AROMA COMPOSITION, AND FOOD AND DRINK AND COSMETICS CONTAINING THE SAME T. HASEGAWA CO., LTD. (JP) 2020-05-21 US disclosed
US-20190223481-A1 STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS CARGILL, INCORPORATED (US) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12458049-B2 Steviol glycoside solubility enhancers SI, TAS2R7, TAS2R31 LMNA 4020/4885SLC15A2 2285/4885EGLN1 659/4885
US-20200157463-A1 PYRROLE COMPOUND, AROMA COMPOSITION, AND FOOD AND DRINK AND COSMETICS CONTAINING THE SAME TAS1R1, TAS2R1, TAS1R2 LMNA 2760/4885SLC15A2 3548/4885EGLN1 1522/4885
US-20260013535-A1 STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS TAS2R7, TAS2R31, TAS2R40 LMNA 4221/4885SLC15A2 797/4885EGLN1 3194/4885
US-20220323528-A1 STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS SI, TAS2R7, TAS2R31 LMNA 4020/4885SLC15A2 2285/4885EGLN1 659/4885
US-11332694-B2 Pyrrole compound, method of making same, and aroma composition, food, drink and cosmetics containing same TAS2R1, TAS1R1, TAS2R10 LMNA 2926/4885SLC15A2 3953/4885EGLN1 1173/4885
US-11717549-B2 Steviol glycoside solubility enhancers SI, TAS2R7, TAS2R31 LMNA 4020/4885SLC15A2 2285/4885EGLN1 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.